Cue Biopharma, Inc. — Director's Dealing 2021

Feb 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2021-02-10

Reporting Person: Millar Kerri-Ann (CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-02-10	Stock Option (right to buy)	$15.55	A	70000	Acquired	2031-02-09	Common Stock (70000)	Direct

Footnotes

F1: This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021.